Review and prospect of clinical application of umbilical cord blood transplantation for 30 years
10.3969/j.issn.1674-7445.2020.02.004
- VernacularTitle:脐血移植临床应用30年的回顾及展望
- Author:
Zimin SUN
1
Author Information
1. Department of Hematology, the First Affiliated Hospital of University of Science and Technology of China, Hefei 230001, China
- Publication Type:Research Article
- Keywords:
Umbilical cord blood transplantation;
Graft-versus-host disease;
Hematopoietic stem cell transplantation;
Malignant tumor of blood system;
Hematopoietic failure disease;
Leukemia;
Stem cell;
Recurrence
- From:
Organ Transplantation
2020;11(2):199-
- CountryChina
- Language:Chinese
-
Abstract:
Hematopoietic stem cell transplantation is a pivotal method to treat hematological malignancies, hematopoietic failure diseases and inherited metabolic diseases. Umbilical cord blood is one of the main sources of hematopoietic stem cells and the most ideal cell source for stem cell research and application. In this article, the clinical application of umbilical cord blood transplantation for more than 30 years was reviewed from the aspects of the history, current situation, advantages, improvement, application prospect and expectation of umbilical cord blood transplantation.
